Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Nanosonics Limited ( (AU:NAN) ) is now available.
UBS Group AG and its related entities have ceased to be substantial shareholders in Nanosonics Limited, a company known for its innovations in infection control solutions. This change in shareholder status, effective from July 10, 2025, may impact the company’s shareholder composition and could have implications for its market strategy and stakeholder interests.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
YTD Price Performance: 30.23%
Average Trading Volume: 878,818
Technical Sentiment Signal: Hold
Current Market Cap: A$1.19B
Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.